Literature DB >> 28345073

Chondrotoxic effects of intra-articular anesthetics in shoulders.

H Alkaduhimi1, D P Ter Meulen1, M P J van den Bekerom1.   

Abstract

Entities:  

Keywords:  Articular; Chondrolysis; Chondrotoxic; Chondrotoxicity; Intra; Sedation; Shoulder

Year:  2017        PMID: 28345073      PMCID: PMC5357092          DOI: 10.1016/j.tjem.2016.11.006

Source DB:  PubMed          Journal:  Turk J Emerg Med        ISSN: 2452-2473


× No keyword cloud information.
Dear editor, With great interest we read the article of Kashani and colleagues “Intra-articular lidocaine versus intravenous sedative and analgesic for reduction of anterior shoulder dislocation”. This article that has been recently published in your journal describes the interesting results of a randomized controlled trial that compared intra-articular lidocaine with intravenous sedation for the treatment of shoulder dislocations. Although we agree with the benefits of intra-articular sedation over local sedation, we feel that possible disadvantages of the use of intra-articular lidocaine have not been properly addressed. Kashani and colleagues do make note of possible chondrolytic effects of local anesthetic injections in the study limitations paragraph but state that it is uncommon. Recent systematic reviews have reported toxic effects of intra-articular use of anesthetics. Sola et al. has also reported an in vivo chondrotoxic effect after a single injection of different concentrations of saline, bupivacaine, ropivacaine, triamcinolone, and a mixture of these agents in the knee joint of rats. Only an injection with a low dose of ropivacaine did not result in chondrotoxicity. Although the effect of bupivacaine seems to be more profound, lidocaine also has chondrotoxic effects as has been shown by Karpie and colleagues. Although sedation with intra-articular lidocaine may have benefits over IV sedation, there are multiple studies that report toxic effects of anesthetics on articular chondrocytes. The objective of this letter is to warn orthopaedic and trauma surgeons in colleagues for these chondrotoxic effect and to use intra-articular local anesthetics with caution, especially in an emergency care population with patients who already suffered an injury to their shoulders' cartilage due to the dislocation. Almost two-thirds of all first-time dislocations at the age of <25 years will develop different stages of arthropathy within 25 years.

Funding

There is no funding for this study.

Conflicts of interest

None declared.
  5 in total

1.  Primary anterior dislocation of the shoulder: long-term prognosis at the age of 40 years or younger.

Authors:  Lennart Hovelius; Hans Rahme
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-01-11       Impact factor: 4.342

2.  The viability of chondrocytes after an in vivo injection of local anaesthetic and/or corticosteroid: a laboratory study using a rat model.

Authors:  M Sola; L Dahners; P Weinhold; A Svetkey van der Horst; S Kallianos; D Flood
Journal:  Bone Joint J       Date:  2015-07       Impact factor: 5.082

3.  Lidocaine exhibits dose- and time-dependent cytotoxic effects on bovine articular chondrocytes in vitro.

Authors:  John C Karpie; Constance R Chu
Journal:  Am J Sports Med       Date:  2007-07-30       Impact factor: 6.202

4.  Articular cartilage and local anaesthetic: A systematic review of the current literature.

Authors:  Abhinav Gulihar; Shibby Robati; Haider Twaij; Alan Salih; Grahame J S Taylor
Journal:  J Orthop       Date:  2015-10-31

5.  Intra-articular lidocaine versus intravenous sedative and analgesic for reduction of anterior shoulder dislocation.

Authors:  Parvin Kashani; Fatemeh Asayesh Zarchi; Hamid Reza Hatamabadi; Abbas Afshar; Marzieh Amiri
Journal:  Turk J Emerg Med       Date:  2016-05-09
  5 in total
  1 in total

1.  Effect of species, concentration and volume of local anesthetics on intervertebral disk degeneration in rats with discoblock.

Authors:  Weiheng Wang; Bing Xiao; Lei Yu; Guoying Deng; Xin Gu; Guohua Xu; Haotian Wang; Junqiang Qi; Yanhai Xi
Journal:  Eur Spine J       Date:  2022-09-24       Impact factor: 2.721

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.